%0 Journal Article
%T Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and Management.
%A Chahine SY
%A Alkhatib KY
%A Arakelyan G
%A Buxton C
%A Giannarini G
%A Hamilton RJ
%A Holt SK
%A Bernhard JC
%A Jiang DM
%A Lin D
%A Liu JJ
%A Manley B
%A Master VA
%A Matveev V
%A Necchi A
%A Packiam VT
%A Patel SH
%A Peak T
%A Peyton CC
%A Pierorazio PM
%A Prakash G
%A Salari K
%A Sexton WJ
%A Singla N
%A Spiess PE
%A Psutka SP
%J Eur Urol Focus
%V 0
%N 0
%D 2024 Aug 14
%M 39147634
%F 5.952
%R 10.1016/j.euf.2024.07.017
%X <B>OBJECTIVE: </B>There are limited data on the prevalence and management of testicular germ cell tumor (TGCT) cases presenting with venous tumor thrombus (VTT). Our objectives were to describe the prevalence of TGCT with VTT, to identify a multicenter retrospective cohort, and to ascertain expert opinion regarding optimal management of this entity.<BR><B>METHODS: </B>Using the IBM Marketscan database, we identified men with testicular cancer who underwent retroperitoneal lymph node dissection (RPLND) with concurrent VTT or inferior vena cava (IVC) tumor thrombectomy to estimate the prevalence of VTT in TGCT. To identify a multicenter retrospective cohort of patients, we surveyed surgeons and described the presentation, management, and outcomes for the cohort.<BR><B>UNASSIGNED: </B>The prevalence of TGCT with VTT in the IBM Marketscan database was 0.3% (n = 7/2517) when using stringent criteria and 3.1% (n = 79/2517) when using broad criteria. In response to our survey, 16 surgeons from ten centers contributed data for 34 patients. Most patients (n = 29, 85%) presented with nonseminomatous germ cell tumor. Surgical management was used for 93.9% (n = 31), including postchemotherapy tumor thrombectomy with primary cavorrhaphy in 63%. The Marketscan analysis was limited to insured individuals and did not include clinicopathological details, and use of billing codes may have included patients with stromal tumors. In addition, lack of responses to the anonymous survey limited data capture, and the RedCap survey did not address symptoms specific to IVC obstruction or allow central review of the imaging leading to VTT diagnosis.<BR><B>CONCLUSIONS: </B>VTT among males with TGCT is rare and requires complex multidisciplinary management, including venous tumor thrombectomy at the time of postchemotherapy RPLND.<BR><B>RESULTS: </B>Using a medical database, we estimated that the frequency of testicular cancer cases in which the tumor extends into a blood vessel (called venous tumor thrombus, VTT) is just 0.3-3.1%. We carried out a survey of surgeons with experience of this condition. Our results indicate that although testicular cancers respond well to chemotherapy, VTT is less responsive and complex surgery is necessary for this rare condition.